Replies to post #23869 on Revive Therapeutics Ltd (RVVTF)

[LT 1990]

You may see EUA filing pr before interm data as study is double blind, if Fda approved EUA then you will get data. Furthermore, we shouldn’t say you will not get interm data. If at any point the dsmb decides say at 400 patients to unblind the study... the company may decide to share some highlight data then. It’s double blind for now and honestly they will blind it for as long as possible to reduce the bias of the study. Your more likely to see an EUA filing PR prior to seeing data as an investor. Between the filing time and EUA approval process the company will hopefully get as many patients through as possible. Right now no one knows for sure how many patients have been run through. Imo we have the 210 group complete and likely working to hit the half way point prior to filing for EUA. With all that being said, I believe as related to the dec 23 pr from rvv they will file for the EUA approval very soon given it seemed they were looking to do so after the interm data analysis was completed imo. Everything is fine, patience we’re getting closer and closer. Cant rush science , we’ve already seen how that’s going for other companies

[trademax42]

Thanks RioDad, appreciated.